The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Table of Contents
Global Bio-Artificial Pancreas Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Bio-Artificial Pancreas Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Portable Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Desktop Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Other Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Bio-Artificial Pancreas Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Bio-Artificial Pancreas Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Bio-Artificial Pancreas Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Bio-Artificial Pancreas Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Bio-Artificial Pancreas Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Bio-Artificial Pancreas Market Assessment by Type
8.1 Asia Pacific Bio-Artificial Pancreas Market Assessment by Application (Consumption and Market Share)
8.2 North America Bio-Artificial Pancreas Market Assessment by Application (Consumption and Market Share)
8.3 Europe Bio-Artificial Pancreas Market Assessment by Application (Consumption and Market Share)
8.4 South America Bio-Artificial Pancreas Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Bio-Artificial Pancreas Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Medtronic
9.1.1 Medtronic Profiles
9.1.2 Medtronic Product Portfolio
9.1.3 Medtronic Bio-Artificial Pancreas Business Performance
9.1.4 Medtronic Bio-Artificial Pancreas Business Development and Market Status
9.2 Beta-O2 Technologies
9.2.1 Beta-O2 Technologies Profiles
9.2.2 Beta-O2 Technologies Product Portfolio
9.2.3 Beta-O2 Technologies Bio-Artificial Pancreas Business Performance
9.2.4 Beta-O2 Technologies Bio-Artificial Pancreas Business Development and Market Status
9.3 JDRF
9.3.1 JDRF Profiles
9.3.2 JDRF Product Portfolio
9.3.3 JDRF Bio-Artificial Pancreas Business Performance
9.3.4 JDRF Bio-Artificial Pancreas Business Development and Market Status
9.4 Defymed
9.4.1 Defymed Profiles
9.4.2 Defymed Product Portfolio
9.4.3 Defymed Bio-Artificial Pancreas Business Performance
9.4.4 Defymed Bio-Artificial Pancreas Business Development and Market Status
9.5 TypeZero Technologies
9.5.1 TypeZero Technologies Profiles
9.5.2 TypeZero Technologies Product Portfolio
9.5.3 TypeZero Technologies Bio-Artificial Pancreas Business Performance
9.5.4 TypeZero Technologies Bio-Artificial Pancreas Business Development and Market Status
9.6 Viacyte
9.6.1 Viacyte Profiles
9.6.2 Viacyte Product Portfolio
9.6.3 Viacyte Bio-Artificial Pancreas Business Performance
9.6.4 Viacyte Bio-Artificial Pancreas Business Development and Market Status
9.7 Insulet
9.7.1 Insulet Profiles
9.7.2 Insulet Product Portfolio
9.7.3 Insulet Bio-Artificial Pancreas Business Performance
9.7.4 Insulet Bio-Artificial Pancreas Business Development and Market Status
9.8 F. Hoffmann-La Roche
9.8.1 F. Hoffmann-La Roche Profiles
9.8.2 F. Hoffmann-La Roche Product Portfolio
9.8.3 F. Hoffmann-La Roche Bio-Artificial Pancreas Business Performance
9.8.4 F. Hoffmann-La Roche Bio-Artificial Pancreas Business Development and Market Status
9.9 Bigfoot Biomedical
9.9.1 Bigfoot Biomedical Profiles
9.9.2 Bigfoot Biomedical Product Portfolio
9.9.3 Bigfoot Biomedical Bio-Artificial Pancreas Business Performance
9.9.4 Bigfoot Biomedical Bio-Artificial Pancreas Business Development and Market Status
9.10 Dexcom
9.10.1 Dexcom Profiles
9.10.2 Dexcom Product Portfolio
9.10.3 Dexcom Bio-Artificial Pancreas Business Performance
9.10.4 Dexcom Bio-Artificial Pancreas Business Development and Market Status
9.11 Johnson & Johnson
9.12 Tandem Diabetes Care
9.13 Beta Bionics
9.14 Inreda Diabetic B.V.
9.15 Cellnovo
10 World Bio-Artificial Pancreas Market Assessment by Players
10.1 Global Bio-Artificial Pancreas Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Bio-Artificial Pancreas Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Bio-Artificial Pancreas Price (USD/Unit) of Players 2014-2020
10.4 Global Bio-Artificial Pancreas Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Bio-Artificial Pancreas Sales Assessment of Players 2014-2020
11.1.2 North America Bio-Artificial Pancreas Revenue Assessment of Players 2014-2020
11.1.3 North America Bio-Artificial Pancreas Price Assessment of Players 2014-2020
11.1.4 North America Bio-Artificial Pancreas Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Bio-Artificial Pancreas Sales Assessment of Players 2014-2020
11.2.2 Europe Bio-Artificial Pancreas Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Bio-Artificial Pancreas Price Assessment of Players 2014-2020
11.2.4 Europe Bio-Artificial Pancreas Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Bio-Artificial Pancreas Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Bio-Artificial Pancreas Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Bio-Artificial Pancreas Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Bio-Artificial Pancreas Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Bio-Artificial Pancreas Sales Assessment of Players 2014-2020
11.4.2 South America Bio-Artificial Pancreas Revenue Assessment of Players 2014-2020
11.4.3 South America Bio-Artificial Pancreas Price Assessment of Players 2014-2020
11.4.4 South America Bio-Artificial Pancreas Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Bio-Artificial Pancreas Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Bio-Artificial Pancreas Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Bio-Artificial Pancreas Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Bio-Artificial Pancreas Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Bio-Artificial Pancreas Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Bio-Artificial Pancreas Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Bio-Artificial Pancreas Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Bio-Artificial Pancreas Sales by Countries/Regions 2014-2020
12.2.2 North America Bio-Artificial Pancreas Revenue by Countries/Regions 2014-2020
12.2.3 North America Bio-Artificial Pancreas Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Bio-Artificial Pancreas Sales by Countries/Regions 2014-2020
12.3.2 Europe Bio-Artificial Pancreas Revenue by Countries/Regions 2014-2020
12.3.3 Europe Bio-Artificial Pancreas Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Bio-Artificial Pancreas Sales by Countries/Regions 2014-2020
12.4.2 South America Bio-Artificial Pancreas Revenue by Countries/Regions 2014-2020
12.4.3 South America Bio-Artificial Pancreas Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Bio-Artificial Pancreas Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Bio-Artificial Pancreas Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Bio-Artificial Pancreas Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Bio-Artificial Pancreas Sales & Revenue Forecast 2021-2026
14.1 World Bio-Artificial Pancreas Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Bio-Artificial PancreasSales and Market Share by Regions
14.1.2 World Bio-Artificial PancreasRevenue and Market Share by Regions
15 Asia Bio-Artificial Pancreas Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Portable
15.1.2 Desktop
15.1.3 Other
15.2 Consumption Forecast by Application, 2021-2026
16 North America Bio-Artificial Pancreas Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Portable
16.1.2 Desktop
16.1.3 Other
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Bio-Artificial Pancreas Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Portable
17.1.2 Desktop
17.1.3 Other
17.2 Consumption Forecast by Application, 2021-2026
18 South America Bio-Artificial Pancreas Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Portable
18.1.2 Desktop
18.1.3 Other
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Bio-Artificial Pancreas Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Portable
19.1.2 Desktop
19.1.3 Other
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Bio-Artificial Pancreas Price (USD/Unit) Trend 2021-2026
20.2 Global Bio-Artificial Pancreas Gross Profit Trend 2021-2026
21 Conclusion
Price : US$ 3,500 | Date : Jan 2025 |
Category : Services | Pages : 167 |
Price : US$ 3,500 | Date : Jan 2025 |
Category : Services | Pages : 132 |
Price : US$ 3,500 | Date : Dec 2024 |
Category : Manufacturing and Construction | Pages : 150 |
Price : US$ 3,500 | Date : Dec 2024 |
Category : Services | Pages : 159 |
Price : US$ 3,500 | Date : Dec 2024 |
Category : Manufacturing and Construction | Pages : 167 |
We will be happy to help you find what you need. Please call us or write to us: